Cellectis SA (CLLS)
1.25
-0.07
(-5.30%)
USD |
NASDAQ |
Apr 02, 10:35
Cellectis Total Liabilities (Quarterly): 252.51M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 38.30M |
| Akari Therapeutics PLC | 9.428M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| Genfit SA | 104.42M |
| Evaxion Biotech AS | 15.18M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 383.54M |
| Shareholders Equity (Quarterly) | 131.03M |
| Debt to Equity Ratio | 0.3727 |
| Current Ratio | 1.726 |
| Net Debt Paydown Yield | -2.60% |